• Citer

Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/ macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia: Final results of a randomized phase III study (06903) of the EORTC Leukemia Cooperative Group

par Zwierzina, Heinz;Suciu, Stefan ;Loeffler, Jay S.;Neuwirtova, Radana;Fenaux, Pierre;Beksac, Meral Sinan;Harousseau, Jean-Luc;Nuessler, Volkmar;Cermak, Jaroslav;Solbu, Gabriel;Willemze, Roel;De Witte, Theo;Amadori, Sergio;Stryckmans, Pierre ;Bron, Dominique ;Louwagie, A.;Selleslag, Dominik;Peetermans, M.;Berneman, Zwi Nisan;Coiffier, Bertrand;Thyss, Antoine;Bourhis, Jean;Fiere, Denis;Zittoun, R;Marie, Jean Pierre;Maraninchi, D.;Baumelou, E.;Lowenberg, B.;Sonnenveld, P.;Gerhartz, Heinrich;Ribeiro, Maíra Marques;Ben-Bassat, Isaac;Labar, Boris;Dardenne, Murielle
Référence Leukemia, 19, 11, page (1929-1933)
Publication Publié, 2005-11

Article révisé par les pairs

• Accès en ligne
• Détails
• Statistiques

Titre:	Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/ macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia: Final results of a randomized phase III study (06903) of the EORTC Leukemia Cooperative Group
Auteur:	Zwierzina, Heinz; Suciu, Stefan; Loeffler, Jay S.; Neuwirtova, Radana; Fenaux, Pierre; Beksac, Meral Sinan; Harousseau, Jean-Luc; Nuessler, Volkmar; Cermak, Jaroslav; Solbu, Gabriel; Willemze, Roel; De Witte, Theo; Amadori, Sergio; Stryckmans, Pierre; Bron, Dominique; Louwagie, A.; Selleslag, Dominik; Peetermans, M.; Berneman, Zwi Nisan; Coiffier, Bertrand; Thyss, Antoine; Bourhis, Jean; Fiere, Denis; Zittoun, R; Marie, Jean Pierre; Maraninchi, D.; Baumelou, E.; Lowenberg, B.; Sonnenveld, P.; Gerhartz, Heinrich; Ribeiro, Maíra Marques; Ben-Bassat, Isaac; Labar, Boris; Dardenne, Murielle
Informations sur la publication:	Leukemia, 19, 11, page (1929-1933)
Statut de publication:	Publié, 2005-11
Sujet CREF:	Cancérologie
	Sciences bio-médicales et agricoles
Mots-clés:	Arabinoside
	GM-CSF
	Interleukin-3
	Low-dose cytosine
	Myelodysplastic syndrome
	Phase III trial
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0887-6924
	info:doi/10.1038/sj.leu.2403934
	info:pii/2403934
	info:scp/27644562303